Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 3/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uliginosin B SCHEMBL20301647 | 0.87 | FASN (0.41) | PTGESALOX5ALDH1A1KDM4EMEN1 | |
| Drummondin A SCHEMBL31237529 | 0.84 | FASN (0.42) | PTGESALOX5ALDH1A1KDM4EMEN1 | |
| SCHEMBL23044011 | 0.81 | PTGES (0.39) | PTGESALOX5ALDH1A1KDM4EMEN1 | |
| SCHEMBL23044078 | 0.78 | PTGES (0.40) | PTGESALOX5ALDH1A1KDM4EMEN1 | |
| SCHEMBL23043805 | 0.77 | KDM4E (0.37) | PTGESALOX5ALDH1A1KDM4EMEN1 | |
| SCHEMBL30450843 | 0.72 | SLC6A2 (0.42) | ALOX5ALDH1A1KDM4EMAPTSMN1; SMN2 | |
| SCHEMBL29929660 | 0.70 | PTGES (0.33) | PTGESALOX5FASN | |
| SCHEMBL29929432 | 0.70 | PTGES (0.33) | PTGESALOX5FASN | |
| SCHEMBL24785845 | 0.63 | KDM4E (0.84) | PTGESALOX5ALDH1A1KDM4EMEN1 | |
| SCHEMBL4742082 | 0.62 | FASN (0.63) | PTGESALOX5FASN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| CN-106729026-A | It is a kind of to treat pharmaceutical composition of cervicitis and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106109550-A | Pharmaceutical composition for the treatment of colon cancer and preparation method thereof | 济南星懿医药技术有限公司 | 2016-11-16 | — | — | CN | claimed |
| CN-105596555-A | Medicine composition for treating liver ascites | JINAN XINGYI MED TECH CO LTD | 2016-05-25 | — | — | CN | claimed |
| CN-105535069-A | Medicine composition for treating coronary heart disease angina | JINAN XINGYI MED TECH CO LTD | 2016-05-04 | — | — | CN | claimed |
| CN-105535228-A | Pharmaceutical composition for treating pancreatic cancer and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-05-04 | — | — | CN | claimed |
| CN-105497251-A | Medicine composition for treating functional dyspepsia | JINAN XINGYI MED TECH CO LTD | 2016-04-20 | — | — | CN | claimed |
| CN-105434508-A | Drug composition for treating vitiligo | JINAN XINGYI MED TECH CO LTD | 2016-03-30 | — | — | CN | claimed |
| CN-105287678-A | Medicinal composition for treating senile constipation | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | claimed |
| CN-105287693-A | Pharmaceutical composition for treating vitiligo and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | claimed |
| CN-105267289-A | Pharmaceutical composition for treating functional dyspepsia and preparation method of pharmaceutical composition | JINAN XINGYI MED TECH CO LTD | 2016-01-27 | — | — | CN | claimed |
| CN-105250445-A | Medicine composition for treating child phlegm-heat obstructing lung type asthma and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-01-20 | — | — | CN | claimed |
| WO-2010092162-A1 | NEUROACTIVE PLANT EXTRACT FROM HYPERICUM POLYANTHEMUM | UNIVERSITE DE ROUEN (FR) | 2010-08-19 | — | — | WO | claimed |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | NATURAL EXTRACTION SYS LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | Natural Extraction Systems, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | disclosed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | disclosed |
| US-20230035892-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | FLAGSHIP PIONEERING, INC. | 2023-02-02 | — | — | US | disclosed |
| US-20220362169-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC | 2022-11-17 | — | — | US | disclosed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| US-11274158-B2 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using calcitonin receptor activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-03-15 | — | — | US | disclosed |
| US-20220033490-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING CHRNA6 INHIBITORS | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2022-02-03 | — | — | US | disclosed |
| US-11208475-B1 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20210283217-A1 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-16 | — | — | US | disclosed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | disclosed |
| US-11059886-B1 | Methods and compositions for treating inflammatory or autoimmune diseases or conditions using GRM8 activators | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2021-07-13 | — | — | US | disclosed |
| US-20210177823-A1 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-06-17 | — | — | US | disclosed |
| US-11034751-B1 | Methods and compositions for treating cancer using serotonin receptor inhibitors | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2021-06-15 | — | — | US | disclosed |
| US-20210154272-A1 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-05-27 | — | — | US | disclosed |
| US-11013717-B1 | Methods and compositions for treating cancer using SERCA pump inhibitors | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2021-05-25 | — | — | US | disclosed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | disclosed |
| US-20200360364-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY OR AUTOIMMUNE DISEASES OR CONDITIONS USING CHRNA6 ACTIVATORS | FLAGSHIP PIONEERING INNOVATIONS V INC (US) | 2020-11-19 | — | — | US | disclosed |
| US-10683352-B1 | Methods for treating cancer using GRM8 inhibitors | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2020-06-16 | — | — | US | disclosed |
| US-10457740-B1 | Methods and compositions for treating cancer using P2RX2 inhibitors | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2019-10-29 | — | — | US | disclosed |
| US-20190240293-A1 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE | CYGNAL THERAPEUTICS, INC. | 2019-08-08 | — | — | US | disclosed |
| US-20190233527-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY OR AUTOIMMUNE DISEASES OR CONDITIONS USING CALCITONIN RECEPTOR ACTIVATORS | FLAGSHIP PIONEERING, INC. | 2019-08-01 | — | — | US | disclosed |
| EP-3490542-A1 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE | Flagship Pioneering Innovations V, Inc. (US) | 2019-06-05 | — | — | EP | disclosed |
| EP-3490581-A2 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER | Flagship Pioneering Innovations V, Inc. (US) | 2019-06-05 | — | — | EP | disclosed |
| WO-2018116054-A1 | COMPOUNDS WITH FUNGICIDAL ACTIVITY | FONDAZIONE EDMUND MACH (IT) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018022668-A2 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER | FLAGSHIP PIONEERING, INC. (US) | 2018-02-01 | — | — | WO | disclosed |
| WO-2018022666-A1 | NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE | FLAGSHIP PIONEERING, INC. (US) | 2018-02-01 | — | — | WO | disclosed |
| CN-106729026-A | It is a kind of to treat pharmaceutical composition of cervicitis and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106729026-A | It is a kind of to treat pharmaceutical composition of cervicitis and preparation method thereof | 济南昊雨青田医药技术有限公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-106109550-A | Pharmaceutical composition for the treatment of colon cancer and preparation method thereof | 济南星懿医药技术有限公司 | 2016-11-16 | — | — | CN | disclosed |
| CN-106109550-A | Pharmaceutical composition for the treatment of colon cancer and preparation method thereof | 济南星懿医药技术有限公司 | 2016-11-16 | — | — | CN | disclosed |
| CN-104222378-B | A kind of health care complex tea and preparation method thereof | 贵州凤冈县仙人岭锌硒有机茶业有限公司 | 2016-08-17 | — | — | CN | disclosed |
| CN-105596555-A | Medicine composition for treating liver ascites | JINAN XINGYI MED TECH CO LTD | 2016-05-25 | — | — | CN | disclosed |
| CN-105535069-A | Medicine composition for treating coronary heart disease angina | JINAN XINGYI MED TECH CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105535228-A | Pharmaceutical composition for treating pancreatic cancer and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105535228-A | Pharmaceutical composition for treating pancreatic cancer and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105535069-A | Medicine composition for treating coronary heart disease angina | JINAN XINGYI MED TECH CO LTD | 2016-05-04 | — | — | CN | disclosed |
| CN-105497251-A | Medicine composition for treating functional dyspepsia | JINAN XINGYI MED TECH CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105497251-A | Medicine composition for treating functional dyspepsia | JINAN XINGYI MED TECH CO LTD | 2016-04-20 | — | — | CN | disclosed |
| CN-105434508-A | Drug composition for treating vitiligo | JINAN XINGYI MED TECH CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105434508-A | Drug composition for treating vitiligo | JINAN XINGYI MED TECH CO LTD | 2016-03-30 | — | — | CN | disclosed |
| CN-105288516-A | Traditional Chinese medicine composition for treating chronic cholecystitis | LU ZHONGXIN | 2016-02-03 | — | — | CN | disclosed |
| CN-105287678-A | Medicinal composition for treating senile constipation | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | disclosed |
| CN-105287693-A | Pharmaceutical composition for treating vitiligo and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | disclosed |
| CN-105287693-A | Pharmaceutical composition for treating vitiligo and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | disclosed |
| CN-105287678-A | Medicinal composition for treating senile constipation | JINAN XINGYI MED TECH CO LTD | 2016-02-03 | — | — | CN | disclosed |
| CN-105267289-A | Pharmaceutical composition for treating functional dyspepsia and preparation method of pharmaceutical composition | JINAN XINGYI MED TECH CO LTD | 2016-01-27 | — | — | CN | disclosed |
| CN-105267289-A | Pharmaceutical composition for treating functional dyspepsia and preparation method of pharmaceutical composition | JINAN XINGYI MED TECH CO LTD | 2016-01-27 | — | — | CN | disclosed |
| CN-105250445-A | Medicine composition for treating child phlegm-heat obstructing lung type asthma and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-01-20 | — | — | CN | disclosed |
| CN-105250445-A | Medicine composition for treating child phlegm-heat obstructing lung type asthma and preparation method thereof | JINAN XINGYI MED TECH CO LTD | 2016-01-20 | — | — | CN | disclosed |
| CN-104825658-A | Liver soothing and qi rectifying preparation for treating liver cancer and preparation method thereof | LI GUIXIANG | 2015-08-12 | — | — | CN | disclosed |
| CN-104622983-A | Traditional Chinese medicine composition for treating proctitis and preparation method thereof | WANG YAN | 2015-05-20 | — | — | CN | disclosed |
| CN-104622984-A | Heat-clearing and dampness-removing preparation for patients suffering proctitis and preparation method thereof | WANG YAN | 2015-05-20 | — | — | CN | disclosed |
| CN-104222378-A | Health compound tea and preparation method thereof | GUIZHOU FENGGANG XIANRENLING ZINC & SELENIUM ORGANIC TEA INDUSTRY CO LTD | 2014-12-24 | — | — | CN | disclosed |
| US-7854946-B1 | Anti-inflammatory and anti-HIV compositions and methods of use | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2010-12-21 | — | — | US | disclosed |
| WO-2010092162-A1 | NEUROACTIVE PLANT EXTRACT FROM HYPERICUM POLYANTHEMUM | UNIVERSITE DE ROUEN (FR) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010092162-A1 | NEUROACTIVE PLANT EXTRACT FROM HYPERICUM POLYANTHEMUM | UNIVERSITE DE ROUEN (FR) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010092162-A1 | NEUROACTIVE PLANT EXTRACT FROM HYPERICUM POLYANTHEMUM | UNIVERSITE DE ROUEN (FR) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010092162-A1 | NEUROACTIVE PLANT EXTRACT FROM HYPERICUM POLYANTHEMUM | UNIVERSITE DE ROUEN (FR) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | PTGES 1679/4885ALOX5 264/4885ALDH1A1 2722/4885 |
| US-20220033490-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING CHRNA6 INHIBITORS | CHRNA6, CHRNA1, CHRNB1 | PTGES 3813/4885ALOX5 2548/4885ALDH1A1 2054/4885 |
| US-12409152-B2 | Compositions and methods related to dissolved oxides | PRKG2, PRKG1, CIT | PTGES 1236/4885ALOX5 260/4885ALDH1A1 4556/4885 |
| US-20200360364-A1 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY OR AUTOIMMUNE DISEASES OR CONDITIONS USING CHRNA6 ACTIVATORS | CHRNA6, CHRNA1, CHRNG | PTGES 1866/4885ALOX5 1887/4885ALDH1A1 3081/4885 |
| US-20260048025-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | SCO2, CNR2, CNR1 | PTGES 338/4885ALOX5 307/4885ALDH1A1 1371/4885 |
| US-20220362169-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | PRKG2, PRKG1, CIT | PTGES 1236/4885ALOX5 260/4885ALDH1A1 4556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.